{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T13:04:59Z","timestamp":1794834299873,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T00:00:00Z","timestamp":1652140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Safety and effectiveness of COVID-19 vaccines during pregnancy is a particular concern affecting vaccination uptake by this vulnerable group. Here we evaluated evidence from 23 studies including 117,552 COVID-19 vaccinated pregnant people, almost exclusively with mRNA vaccines. We show that the effectiveness of mRNA vaccination against RT-PCR confirmed SARS-CoV-2 infection 7 days after second dose was 89\u00b75% (95% CI 69\u00b70-96\u00b74%, 18,828 vaccinated pregnant people,\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200973\u00b79%). The risk of stillbirth was significantly lower in the vaccinated cohort by 15% (pooled OR 0\u00b785; 95% CI 0\u00b773\u20130\u00b799, 66,067 vaccinated vs. 424,624 unvaccinated,\n                    <jats:italic>I<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u200993\u00b79%). There was no evidence of a higher risk of adverse outcomes including miscarriage, earlier gestation at birth, placental abruption, pulmonary embolism, postpartum haemorrhage, maternal death, intensive care unit admission, lower birthweight Z-score, or neonatal intensive care unit admission (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&gt;\u20090.05 for all). COVID-19 mRNA vaccination in pregnancy appears to be safe and is associated with a reduction in stillbirth.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-30052-w","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T06:03:22Z","timestamp":1652162602000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":273,"title":["Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy"],"prefix":"10.1038","volume":"13","author":[{"given":"Smriti","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Kalafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4000-8923","authenticated-orcid":false,"given":"Helena","family":"Blakeway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pat","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Draycott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakila","family":"Thangaratinam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"von Dadelszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Heath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2802-7670","authenticated-orcid":false,"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,10]]},"reference":[{"key":"30052_CR1","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"30052_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"30052_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23938-8","volume":"12","author":"J Viana","year":"2021","unstructured":"Viana, J. et al. Controlling the pandemic during the SARS-CoV-2 vaccination rollout. Nat. Commun. 12, 3674 (2021).","journal-title":"Nat. Commun."},{"key":"30052_CR4","unstructured":"ACOG. COVID-19 Vaccination Considerations for Obstetric\u2013gynecologic Care, December 2020 (ACOG, accessed 25 August 2021); https:\/\/www.acog.org\/clinical\/clinical-guidance\/practice-advisory\/articles\/2020\/12\/covid-19-vaccination-considerations-for-obstetric-gynecologic-care."},{"key":"30052_CR5","unstructured":"PHE. JCVI Issues New Advice on COVID-19 Vaccination for Pregnant Women, 2021 [PHE, accessed 25 August 2021); https:\/\/www.gov.uk\/government\/news\/jcvi-issues-new-advice-on-covid-19-vaccination-for-pregnant-women."},{"key":"30052_CR6","doi-asserted-by":"publisher","unstructured":"Shook, L. L., Kishkovich, T. P. & Edlow, A. G. Countering COVID-19 vaccine hesitancy in pregnancy: the \u20184 Cs\u2019. Am. J. Perinatol. https:\/\/doi.org\/10.1055\/a-1673-5546 (2021).","DOI":"10.1055\/a-1673-5546"},{"key":"30052_CR7","doi-asserted-by":"publisher","first-page":"n2862","DOI":"10.1136\/bmj.n2862","volume":"375","author":"G Iacobucci","year":"2021","unstructured":"Iacobucci, G. Covid-19 and pregnancy: vaccine hesitancy and how to overcome it. BMJ 375, n2862 (2021).","journal-title":"BMJ"},{"key":"30052_CR8","doi-asserted-by":"publisher","unstructured":"Blakeway, H. et al. COVID-19 vaccination during pregnancy: coverage and safety. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2021.08.007 (2021).","DOI":"10.1016\/j.ajog.2021.08.007"},{"key":"30052_CR9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1001\/jamapediatrics.2021.1050","volume":"175","author":"J Villar","year":"2021","unstructured":"Villar, J. et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort Study. JAMA Pediatr. 175, 817\u2013826 (2021).","journal-title":"JAMA Pediatr."},{"key":"30052_CR10","doi-asserted-by":"publisher","first-page":"m3320","DOI":"10.1136\/bmj.m3320","volume":"370","author":"J Allotey","year":"2020","unstructured":"Allotey, J. et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 370, m3320 (2020).","journal-title":"BMJ"},{"key":"30052_CR11","doi-asserted-by":"crossref","unstructured":"Vousden, N. et al. Severity of maternal infection and perinatal outcomes during periods of SARS-CoV-2 wildtype, alpha, and delta variant dominance in the UK: prospective cohort study. BMJ Medicine 1, (2022).","DOI":"10.1136\/bmjmed-2021-000053"},{"key":"30052_CR12","unstructured":"NPEU. Pregnant Women Now a Priority Group for COVID-19 Vaccination (NPEU, accessed 12 January 2022); https:\/\/www.npeu.ox.ac.uk\/news\/2194-pregnant-women-now-a-priority-group-for-covid-19-vaccination."},{"key":"30052_CR13","doi-asserted-by":"publisher","unstructured":"Bookstein Peretz, S. et al. Short-term outcome of pregnant women vaccinated by BNT162b2 mRNA COVID-19 vaccine. Ultrasound Obstet. Gynecol. https:\/\/doi.org\/10.1002\/uog.23729 (2021).","DOI":"10.1002\/uog.23729"},{"key":"30052_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.reprotox.2021.05.007","volume":"103","author":"CJ Bowman","year":"2021","unstructured":"Bowman, C. J. et al. Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod. Toxicol. 103, 28\u201335 (2021).","journal-title":"Reprod. Toxicol."},{"key":"30052_CR15","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1056\/NEJMoa2104983","volume":"384","author":"TT Shimabukuro","year":"2021","unstructured":"Shimabukuro, T. T. et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N. Engl. J. Med. 384, 2273\u20132282 (2021).","journal-title":"N. Engl. J. Med."},{"key":"30052_CR16","doi-asserted-by":"publisher","first-page":"100464","DOI":"10.1016\/j.ajogmf.2021.100464","volume":"3","author":"ME Trostle","year":"2021","unstructured":"Trostle, M. E. et al. COVID-19 vaccination in pregnancy: early experience from a single institution. Am. J. Obstet. Gynecol. MFM 3, 100464\u2013100464 (2021).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"30052_CR17","doi-asserted-by":"publisher","unstructured":"Zauche, L. H. et al. Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMc2113891 (2021).","DOI":"10.1056\/NEJMc2113891"},{"key":"30052_CR18","unstructured":"Pfizer. Pfizer and biontech commence global clinical trial to evaluate covid-19 vaccine in pregnant women, 2021 (Pfizer, accessed 26 August 2021) https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-commence-global-clinical-trial-evaluate."},{"key":"30052_CR19","unstructured":"Beharier, O. et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J. Clin. Investig. 131, e150319 (2021)."},{"key":"30052_CR20","doi-asserted-by":"publisher","first-page":"6535","DOI":"10.1016\/j.vaccine.2021.09.043","volume":"39","author":"I Bleicher","year":"2021","unstructured":"Bleicher, I., Kadour-Peero, E., Sagi-Dain, L. & Sagi, S. Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study. Vaccine 39, 6535\u20136538 (2021).","journal-title":"Vaccine"},{"key":"30052_CR21","unstructured":"Number of Live and Stillbirths Among Infants Born in Ontario, by COVID-19 Vaccination Status; 2021 (accessed 12 January 2022) https:\/\/www.bornontario.ca\/en\/news\/number-of-live-and-stillbirths-among-infants-born-in-ontario-by-covid-19-vaccination-status.aspx."},{"key":"30052_CR22","doi-asserted-by":"publisher","unstructured":"Butt, A. A. et al. SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women. J. Clin. Investig. 131, (2021) https:\/\/doi.org\/10.1172\/JCI153662.","DOI":"10.1172\/JCI153662"},{"key":"30052_CR23","doi-asserted-by":"publisher","unstructured":"Dagan, N. et al. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-021-01490-8 (2021).","DOI":"10.1038\/s41591-021-01490-8"},{"key":"30052_CR24","doi-asserted-by":"publisher","unstructured":"Goldshtein, I. et al. Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women. JAMA https:\/\/doi.org\/10.1001\/jama.2021.11035 (2021).","DOI":"10.1001\/jama.2021.11035"},{"key":"30052_CR25","doi-asserted-by":"publisher","unstructured":"Gray, K. J. et al. Coronavirus disease 2019 vaccine response in pregnant and lactating women: a cohort study. Am. J. Obstet. Gynecol. https:\/\/doi.org\/10.1016\/j.ajog.2021.03.023 (2021).","DOI":"10.1016\/j.ajog.2021.03.023"},{"key":"30052_CR26","doi-asserted-by":"publisher","first-page":"e2121310","DOI":"10.1001\/jamanetworkopen.2021.21310","volume":"4","author":"A Kachikis","year":"2021","unstructured":"Kachikis, A. et al. Short-term reactions among pregnant and lactating individuals in the first wave of the COVID-19 vaccine rollout. JAMA Netw. Open 4, e2121310\u2013e2121310 (2021).","journal-title":"JAMA Netw. Open"},{"key":"30052_CR27","doi-asserted-by":"publisher","unstructured":"Kharbanda, E. O. et al. Spontaneous abortion following COVID-19 vaccination during pregnancy. JAMA https:\/\/doi.org\/10.1001\/jama.2021.15494 (2021).","DOI":"10.1001\/jama.2021.15494"},{"key":"30052_CR28","doi-asserted-by":"publisher","unstructured":"Lipkind H. S. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth\u2014Eight Integrated Health Care Organizations, United States, December 15, 2020\u2013July 22, 2021. MMWR Morb. Mortal. Wkly. Rep. 71, https:\/\/doi.org\/10.15585\/mmwr.mm7101e1 (2022).","DOI":"10.15585\/mmwr.mm7101e1"},{"key":"30052_CR29","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1056\/NEJMc2114466","volume":"385","author":"MC Magnus","year":"2021","unstructured":"Magnus, M. C. et al. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N. Engl. J. Med. 385, 2008\u20132010 (2021).","journal-title":"N. Engl. J. Med."},{"key":"30052_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/AOG.0000000000004621","volume":"139","author":"JA Morgan","year":"2022","unstructured":"Morgan, J. A. et al. Maternal outcomes after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in vaccinated compared with unvaccinated pregnant patients. Obstet. Gynecol. 139, 107\u2013109 (2022).","journal-title":"Obstet. Gynecol."},{"key":"30052_CR31","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/1471-0528.16941","volume":"129","author":"M Rottenstreich","year":"2022","unstructured":"Rottenstreich, M. et al. Covid-19 vaccination during the third trimester of pregnancy: rate of vaccination and maternal and neonatal outcomes, a multicentre retrospective cohort study. BJOG 129, 248\u2013255 (2022).","journal-title":"BJOG"},{"key":"30052_CR32","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.ajogmf.2021.100467","volume":"3","author":"RN Theiler","year":"2021","unstructured":"Theiler, R. N. et al. Pregnancy and birth outcomes after SARS-CoV-2 vaccination in pregnancy. Am. J. Obstet. Gynecol. MFM 3, 100467 (2021).","journal-title":"Am. J. Obstet. Gynecol. MFM"},{"key":"30052_CR33","unstructured":"GOV.UK. COVID-19 vaccine weekly surveillance reports (weeks 39 to 1, 2021 to 2022). (GOV.UK, accessed 12 January 2022); https:\/\/www.gov.uk\/government\/publications\/covid-19-vaccine-weekly-surveillance-reports."},{"key":"30052_CR34","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.1016\/j.vaccine.2021.09.012","volume":"39","author":"T Wainstock","year":"2021","unstructured":"Wainstock, T., Yoles, I., Sergienko, R. & Sheiner, E. Prenatal maternal COVID-19 vaccination and pregnancy outcomes. Vaccine 39, 6037\u20136040 (2021).","journal-title":"Vaccine"},{"key":"30052_CR35","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2020","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2020).","journal-title":"N. Engl. J. Med."},{"key":"30052_CR36","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(21)02282-0","volume":"398","author":"K Hillson","year":"2021","unstructured":"Hillson, K. et al. Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination. Lancet 398, 1683\u20131684 (2021).","journal-title":"Lancet"},{"key":"30052_CR37","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff, J. et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N. Engl. J. Med. 384, 2187\u20132201 (2021).","journal-title":"N. Engl. J. Med."},{"key":"30052_CR38","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/uog.20189","volume":"53","author":"R Townsend","year":"2019","unstructured":"Townsend, R. et al. Variation in outcome reporting in randomized controlled trials of interventions for prevention and treatment of fetal growth restriction. Ultrasound Obstet. Gynecol. 53, 598\u2013608 (2019).","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"30052_CR39","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(22)00166-0","volume":"399","author":"E Kalafat","year":"2022","unstructured":"Kalafat, E., Magee, L. A., von Dadelszen, P., Heath, P. & Khalil, A. COVID-19 booster doses in pregnancy and global vaccine equity. Lancet 399, 907\u2013908 (2022).","journal-title":"Lancet"},{"key":"30052_CR40","unstructured":"World Health Organization. Most Recent Vaccine Policy Positions (World Health Organization, accessed 12 January 2021); https:\/\/www.comitglobal.org\/authority\/who."},{"key":"30052_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1728-4465.2010.00250.x","volume":"41","author":"S Singh","year":"2010","unstructured":"Singh, S., Sedgh, G. & Hussain, R. Unintended pregnancy: worldwide levels, trends, and outcomes. Stud. Fam. Plann 41, 241\u2013250 (2010).","journal-title":"Stud. Fam. Plann"},{"key":"30052_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","volume":"63","author":"S Saito","year":"2010","unstructured":"Saito, S., Nakashima, A., Shima, T. & Ito, M. Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63, 601\u2013610 (2010).","journal-title":"Am. J. Reprod. Immunol."},{"key":"30052_CR43","doi-asserted-by":"publisher","unstructured":"DeSisto, C. L. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization\u2014United States, March 2020\u2013September 2021. MMWR Morb. Mortal. Wkly. Rep. 70, https:\/\/doi.org\/10.15585\/mmwr.mm7047e1 (2021).","DOI":"10.15585\/mmwr.mm7047e1"},{"key":"30052_CR44","doi-asserted-by":"publisher","unstructured":"Stock, S. J. et al. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nat. Med. 10, https:\/\/doi.org\/10.1038\/s41591-021-01666-2 (2022).","DOI":"10.1038\/s41591-021-01666-2"},{"key":"30052_CR45","unstructured":"Fonseca, P. & Brito, R. Brazil suspends use of AstraZeneca vaccine in pregnant women nationally after death. Reuters 2021 (accessed 12 January 2022); https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/brazil-health-agency-calls-halt-astrazeneca-vaccine-pregnant-women-2021-05-11\/ ."},{"key":"30052_CR46","doi-asserted-by":"publisher","unstructured":"Wolf, M. E. et al. Thrombocytopenia and intracranial venous sinus thrombosis after \u201cCOVID-19 vaccine AstraZeneca\u201d exposure. J. Clin. Med. 10, https:\/\/doi.org\/10.3390\/jcm10081599 (2021).","DOI":"10.3390\/jcm10081599"},{"key":"30052_CR47","doi-asserted-by":"publisher","unstructured":"Mendes-de-Almeida, D. P. et al. Intracerebral hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following ChAdOx1 nCOVID-19 vaccine in a pregnant woman. Haematologica https:\/\/doi.org\/10.3324\/haematol.2021.279407 (2021).","DOI":"10.3324\/haematol.2021.279407"},{"key":"30052_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","volume":"144","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B., Kamat, I. & Hotez, P. J. Myocarditis with COVID-19 mRNA vaccines. Circulation 144, 471\u2013484 (2021).","journal-title":"Circulation"},{"key":"30052_CR49","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1016\/j.hrthm.2020.05.001","volume":"17","author":"B Siripanthong","year":"2020","unstructured":"Siripanthong, B. et al. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 17, 1463\u20131471 (2020).","journal-title":"Heart Rhythm"},{"key":"30052_CR50","unstructured":"Royal College of Obstetricians and Gynaecologists. Maternity Colleges Express Concern Over Vaccine Hesitancy in Pregnant Women, 2021 (Royal College of Obstetricians and Gynaecologists, accessed 25 August 2021); https:\/\/www.rcog.org.uk\/en\/news\/maternity-colleges-express-concern-over-vaccine-hesitancy-in-pregnant-women\/."},{"key":"30052_CR51","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.2147\/PPA.S338932","volume":"15","author":"M Samannodi","year":"2021","unstructured":"Samannodi, M. COVID-19 vaccine acceptability among women who are pregnant or planning for pregnancy in saudi arabia: a Cross-Sectional Study. Patient Prefer Adherence 15, 2609\u20132618 (2021).","journal-title":"Patient Prefer Adherence"},{"key":"30052_CR52","doi-asserted-by":"publisher","unstructured":"Schaal, N. K., Z\u00f6llkau, J., Hepp, P., Fehm, T. & Hagenbeck, C. Pregnant and breastfeeding women\u2019s attitudes and fears regarding the COVID-19 vaccination. Arch. Gynecol. Obstet. https:\/\/doi.org\/10.1007\/s00404-021-06297-z (2021).","DOI":"10.1007\/s00404-021-06297-z"},{"key":"30052_CR53","unstructured":"Joint Committee on Vaccination and Immunisation. Advice on Priority groups for COVID-19 Vaccination, 2021 (Joint Committee on Vaccination and Immunisation, accessed 25 August 2021); https:\/\/www.gov.uk\/government\/publications\/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020\/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020."},{"key":"30052_CR54","unstructured":"Royal College of Obstetricians and Gynaecologists. Coronavirus (COVID-19) Vaccination in Pregnancy, Information for Healthcare Professionals, 2021 (Royal College of Obstetricians and Gynaecologists, accessed 25 August 2021); https:\/\/www.rcog.org.uk\/covid-vaccine."},{"key":"30052_CR55","unstructured":"CDC. Vaccination Considerations for People Pregnant or Breastfeeding, 2022 (Centers for Disease Control and Prevention, accessed 4 February 2022); https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/recommendations\/pregnancy.html."},{"key":"30052_CR56","unstructured":"Royal College of Obstetricians & Gynaecologists. COVID-19 Vaccines, Pregnancy and Breastfeeding (Royal College of Obstetricians & Gynaecologists, Accessed 4 February 2022); https:\/\/www.rcog.org.uk\/en\/guidelines-research-services\/coronavirus-covid-19-pregnancy-and-womens-health\/covid-19-vaccines-and-pregnancy\/covid-19-vaccines-pregnancy-and-breastfeeding\/."},{"key":"30052_CR57","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1002\/sim.4040","volume":"29","author":"T Stijnen","year":"2010","unstructured":"Stijnen, T., Hamza, T. H. & \u00d6zdemir, P. Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data. Stat. Med. 29, 3046\u20133067 (2010).","journal-title":"Stat. Med."},{"key":"30052_CR58","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/sim.4780122405","volume":"12","author":"HC Van Houwelingen","year":"1993","unstructured":"Van Houwelingen, H. C., Zwinderman, K. H. & Stijnen, T. A bivariate approach to meta-analysis. Stat. Med. 12, 2273\u20132284 (1993).","journal-title":"Stat. Med."},{"key":"30052_CR59","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JPT Higgins","year":"2002","unstructured":"Higgins, J. P. T. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539\u20131558 (2002).","journal-title":"Stat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30052-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30052-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30052-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:04:35Z","timestamp":1669291475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-30052-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["30052"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-30052-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,10]]},"assertion":[{"value":"12 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.O.B. is co-chair of the Royal College of Obstetricians and Gynaecologists (RCOG) Vaccine Committee. P.O.B. and T.D. are RCOG Vice-Presidents. E.M. is RCOG President. P.H. is a member of the RCOG Vaccine Committee. P.H. is CI of the Preg-Cov trial (UK multicentre COVID vaccination in pregnancy). A.K. is obstetric PI of the Preg-Cov trial (UK multicentre COVID vaccination in pregnancy). A.K. is a member of the COVAX Working Group on COVID vaccination in pregnancy. A.K. is PI of the Pfizer COVID vaccination in pregnancy trial. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2414"}}